Sodium Valproate: Compensation
Commons · Question 107359 · Tabled 21 Jan 2026 · Ministry of Justice · Official record
Answered 30 Jan 2026
Question
Asked by Bob Blackman
To ask the Secretary of State for Justice, what assessment he has made of the potential impact of the withdrawal of legal aid in cases involving sodium valproate on the long-term care needs on people who have brought such cases forward.
Answer
Answered by Sarah Sackman, 30 Jan 2026
Legal aid was granted in respect of a multi-party action product liability dispute under the Consumer Protection Act 1987 against Sanofi, the manufacturers of Epilim, a sodium valproate containing medication. The availability of legal aid in connection wi...